Immix Biopharma, Inc. - Common Stock (IMMX)

CUSIP: 45258H106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
52,769,253
Total 13F shares
405,051
Share change
-251,851
Total reported value
$1,385,659
Price per share
$3.42
Number of holders
16
Value change
-$652,595
Number of buys
10
Number of sells
5

Security key

45258H106

Report period

Q3 2023

Institutions

16

Top holders

10

Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Lynwood Capital Management Inc.
13F
Company
0.38%
200,250
$538,673 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
0.2%
105,357
$283,410 30 Jun 2023
13F
UMB Bank, n.a.
13F
Company
0.14%
72,639
$195,399 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.11%
60,326
$162,276 30 Jun 2023
13F
Koshinski Asset Management, Inc.
13F
Company
0.1%
51,001
$137,193 30 Jun 2023
13F
STATE STREET CORP
13F
Company
0.08%
42,960
$115,562 30 Jun 2023
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.04%
22,825
$61,000 30 Jun 2023
13F
Imprint Wealth LLC
13F
Company
0.04%
22,280
$42,332 30 Jun 2023
13F
Moss Adams Wealth Advisors LLC
13F
Company
0.04%
20,000
$53,800 30 Jun 2023
13F
InterOcean Capital Group, LLC
13F
Company
0.03%
15,900
$42,771 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
0.03%
15,648
$42,093 30 Jun 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.02%
11,911
$32,041 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
10,600
$29,000 30 Jun 2023
13F
Parallel Advisors, LLC
13F
Company
0.01%
2,890
$7,774 30 Jun 2023
13F
Tortoise Investment Management, LLC
13F
Company
0%
1,000
$2,690 30 Jun 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
350
$941 30 Jun 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
120
$323 30 Jun 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
42
$113 30 Jun 2023
13F
Sean Senn
3/4/5
Under 10% owner
class O/S missing
899,800
$4,205,665 14 Jul 2022
Vladimir P. Torchilin
3/4/5
Scientific Co-Founder
class O/S missing
905,200
$4,230,905 20 Dec 2021

Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2023

As of 30 Sep 2023, Immix Biopharma, Inc. - Common Stock (IMMX) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 405,051 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Koshinski Asset Management, Inc., STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, Imprint Wealth LLC, Moss Adams Wealth Advisors LLC, BlackRock Inc., InterOcean Capital Group, LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P.. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
17
Q3 2023 holders
16
Holder diff
-1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .